Trial of the route of early nutritional support in critically ill adults
CALORIES trial design and results
Design
Multicentre pragmatic randomised controlled trial
Treatment
Early parenteral nutrition
Control
Early enteral nutrition
Population
2388 analysed critically ill adults: 1191 parenteral and 1197 enteral
Follow-up
90 days
Primary endpoint
All-cause mortality at 30 days
Result
By 30 days, 393 of 1188 patients (33.1%) in the parenteral group had died, with no significant difference from the enteral group. Treated infectious complications did not differ between the parenteral and enteral groups (mean 0.22 versus 0.21 per patient).
Secondary endpoints
Infectious complications, hypoglycaemia, vomiting, organ support
We found no significant difference in 30-day mortality associated with the route of delivery of early nutritional support in critically ill adults.
The trial authors, in the published abstract
How it has aged
Dismantled the belief that the parenteral route is intrinsically dangerous. Enteral feeding remains first choice for practical reasons, but the trial removes the moral weight that used to attach to the decision.
Publications
Trial of the route of early nutritional support in critically ill adults
Harvey SE, Parrott F, Harrison DA, et al. Trial of the route of early nutritional support in critically ill adults. N Engl J Med 2014 Oct 30;371(18):1673-84.
No difference in 30-day mortality by route
Fewer episodes of hypoglycaemia and vomiting with parenteral nutrition